AbSTRACT AIMS -This paper explores different approaches to quantify the human costs related to drug use. DATA AND METHODS -The data come from a representative survey of 3092 respondents above the age of 18 in four Nordic capitals: Copenhagen, Helsinki, Oslo and Stockholm. RESULTS -The results show that in most Nordic capitals more than half of the respondents at some time have known and worried about the drug use of somebody they know personally. Moreover, while the average reported harm was about 2 on a scale from 0 to 10, a significant minority (10%) of those knowing drug users indicated that the harm was above 5. CONCLUSIONS -Many persons have at some time personally known somebody who uses drugs. This causes significant human harm and should be included in the estimate of the social cost of illegal drugs. These results are relevant in the debate on the size of the drug problem as well as for targeting groups that experience the highest costs.
Introduction
Mark kleiman (1999) has argued that the standard method of estimating the economic cost of illicit drugs "ignores the profound day-to-day harm living with addiction imposes on addicts and their intim ates." to illustrate the importance of this he employed a back-of-the envelope analysis, which suggested that including human harm would increase the estimated cost of drugs in the study presented in Harwood et al. (1998) by more than 80%.
this estimate assumes that the drug user, family and friends together are willing to pay 10 000 usd for a year's remission. the quantification of human harm is important in itself, but it also has important policy implications. the immediate consequence of leaving out human harm is to a monetary value on something, they tend to give answers that reflect an underlying opinion more than a true quantification ("drug treatment is a good thing, i will support it") or an answer that is largely influenced by random factors. these problems imply that in addition to asking about monetary valuations, one should also explore quantifications which may be easier for respondents to understand.
there is also a relevant literature on measuring harm in general and using harm reduction as a policy goal (nutt et al. 2010) . this research has stimulated sever- French & Martin 1996; single et al. 1998; Culyer et al. 2002) . When those who knew drug users were asked to what extent the drug use had affected them on a scale from 0 (no harm)
to 10 ("it has ruined my life"), the average answer was between 2 and 2.6 in a life perspective and slightly higher than 1 during the past year in all capitals (see or more on a scale where 0 is no negative effect and 10 is ì it has ruined my lifeî would you say it has it affected your life on a scale from 0 to 10 (0 is no negative consequences and 10 is ì it has ruined my lifeî )
Figure 2. gender differences in harm. if you know somebody who use drugs regularly, how would you say it has it affected your life on a scale from 0 to 10 (0 is no negative consequences and 10 is "it has ruined my life") Levels of harms Table 6 . "if you know somebody who uses drugs regularly, how would you say it has it affected you on a scale from 0 to 10 (0 is "no negative consequences" and 10 is "it has ruined my life") the differences between the countries are also evident in the regression results, with "living in Helsinki" leading to a score that is lower on the subjective harm index compared to the benchmark country (sweden).
the regression results confirm that the patterns found when examining one factor at a time in a cross-table also hold when we consider the factors collectively. 
Harm measured in money?
social costs are often measured in money.
is it possible to quantify the harm suffered 
Extensions and limitations

Conclusions
Our results show that it is important to include human harm to get a more accurate picture of the overall cost of drugs in so- estimating the willingness to pay for drug abuse treatment: a pilot study. Journal of substance abuse treatment 18 (2):149-159.
